Louis J. Aronne serves as Executive at Atlas Therapeutics Corp, where they oversee executive responsibilities. Since joining the company, Louis J. Aronne has executed 7 insider transactions totaling $48.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 31, 2020 involved receiving (via award) 29,752 shares valued at $0.
Louis J. Aronne currently holds 80,705 shares of Atlas Therapeutics Corp (ATTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis J. Aronne has been a net buyer of ATTH stock. They have purchased $48.8K and sold $0 worth of shares.
Louis J. Aronne's most recent insider trade was on Mar 31, 2020, when they sold 29,752 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 3, 2018 | MYOS | $0 | Award | 9,191 | $N/A | Discretionary |
| Sep 4, 2015 | MYOS | $8.8K | Purchase | 5,000 | $1.76 | Discretionary |
| Mar 3, 2014 | MYOS | $0 | Award | 2,000 | $N/A | Discretionary |
| Jul 6, 2012 | MYOS | $40.0K | Purchase | 160,000 | $0.25 | Discretionary |
| Jul 14, 2011 | ATTH | $0 | Award | 600,000 | $N/A | Discretionary |